Vis Ethic Research
Vis Ethic Research is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
A multicenter open-label phase II study of Cemiplimab plus chemotherapy, selected on the basis of baseline cytidine deaminase activity, in advanced squamous non-small cell lung cancer - CECYDE trial - GOIRC-04-2024
Sponsor G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Maintenance AVElumab after SECond line platinum-based chemotherapy for metastatic urothelial carcinoma: AVESEC trial - GOIRC-02-2025
Sponsor G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcoma
Sponsor Associazione Italiana Ematologia Oncologia Pediatrica
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Vis Ethic Research?
The 2026-10-09 snapshot links Vis Ethic Research to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Project management, Quality assurance & auditing, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Vis Ethic Research?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Vis Ethic Research conducted?
The linked trials record locations in 11 countries, including Italy, Austria, Belgium, Czechia, Germany. These are trial locations, not confirmed office locations or countries where Vis Ethic Research delivered services.
What can this page tell me about Vis Ethic Research's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Vis Ethic Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Vis Ethic Research S.r.l.